<?xml version="1.0" encoding="UTF-8"?>
<ref id="pbi13194-bib-0051">
 <mixed-citation publication-type="journal" id="pbi13194-cit-0051">
  <string-name>
   <surname>Zeitlin</surname>, 
   <given-names>L.</given-names>
  </string-name>, 
  <string-name>
   <surname>Pettitt</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Scully</surname>, 
   <given-names>C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Bohorova</surname>, 
   <given-names>N.</given-names>
  </string-name>, 
  <string-name>
   <surname>Kim</surname>, 
   <given-names>D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Pauly</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Hiatt</surname>, 
   <given-names>A.</given-names>
  </string-name>
  <italic>et al</italic> (
  <year>2011</year>) 
  <article-title>Enhanced potency of a fucose‐free monoclonal antibody being developed as an Ebola virus immunoprotectant</article-title>. 
  <source xml:lang="en">Proc. Natl. Acad. Sci. USA</source>, 
  <volume>108</volume>, 
  <fpage>20690</fpage>–
  <lpage>20694</lpage>.
  <pub-id pub-id-type="pmid">22143789</pub-id>
 </mixed-citation>
</ref>
